Moreover, we showed that miR-155 plays an important role in CML pathogenicity by enforcing CD34+ cells to escape from the growth-inhibitory effects of TGF-β1 and BMP signaling. The gene discussed is TGFB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.